Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 5Lymphoma 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Multiple Myeloma 3Mucositis 3Leukemia 3Hodgkin Disease 3Head and Neck Neoplasms 3Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Graft vs Host Disease 2Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma 1Recurrence 1Radiation Injuries 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pain 1Oral Ulcer 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1

Interventions

Cisplatin 4Cetuximab 4Pemetrexed 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gemcitabine 2pembrolizumab 1monalizumab 1durvalumab 1X-Rays 1Vitamin B 12 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Proflavine 1Paclitaxel 1Modafinil 1Minocycline 1Metformin 1Gefitinib 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Drug Therapy 1Docetaxel 1Chemical Fractionation 1Carboplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Diseases × Fibroblast Growth Factor 7 × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡